Biocon's Pertuzumab Receives Marketing Authorization in EU, First Biosimilar Authorized Under EMA's New Tailored Clinical Approach
<p>EC approval follows recent U.S. FDA approval of Biocon's pertuzumab biosimilar Provides an additional treatment option for patients with HER2-positive breast cancer and may support more sustainable healthcare systems in Europe The milestone further strengthens Biocon's growing oncology...</p>
Read original article ↗
Related Articles
Les représentants commerciaux et les responsables des relations médicales peuvent lancer ACTO CxZone en un clic depuis l
Sales reps and MSLs can launch ACTO CxZone with one click from their planning screens, practice with an HCP avatar groun
Vertriebsmitarbeiter und MSLs können ACTO CxZone mit einem Klick von ihren Planungsbildschirmen aus starten, mit einem H
Gopuff Joins the Swish Network to Expand Targeted, Measurable Product Sampling
Partnership gives brands more ways to reach high-potential customers through Gopuff, with the flexibility to activate ca